<DOC>
	<DOCNO>NCT02555319</DOCNO>
	<brief_summary>The purpose study evaluate safety short-term effectiveness implantation Transcatheter Pulmonary Valve ( TPV ) treatment congenital heart disease pulmonary valve disease .</brief_summary>
	<brief_title>A Feasibility Study Evaluate Safety Short-term Effectiveness Transcatheter Pulmonary Valve ( TPV )</brief_title>
	<detailed_description>Diverse congenital heart diseases involve pulmonary artery , Tetralogy Fallot ( TOF ) without pulmonary atresia , transposition great artery pulmonary stenosis , require implantation artificial conduit right ventricle pulmonary artery ( PA ) . Because conduit finally degenerate result pulmonary regurgitation and/or stenosis progressive right ventricle ( RV ) dilation eventual failure , patient need repetitive surgery conduit revision . Transcatheter pulmonary valve implantation ( TPVI ) less invasive alternative surgery patient dysfunctional right ventricular outflow tract ( RVOT ) . TPV large-diameter ( 28 mm ) self-expandable stent relatively low profile nitinol wire backbone valve leaflet make porcine pericardial tissue . The TPV indicate use patient previous undergone replacement bioprosthetic valve conduit due either pulmonary valve atresia , stenosis , regurgitation combination present dysfunctional RVOT require treatment severe pulmonary regurgitation and/or RVOT conduit obstruction . Consecutive subject data collect discharge , 1 , 3 , 6 month , 1-5 year post TPV implantation .</detailed_description>
	<mesh_term>Heart Defects , Congenital</mesh_term>
	<mesh_term>Cardiovascular Abnormalities</mesh_term>
	<mesh_term>Pulmonary Valve Insufficiency</mesh_term>
	<mesh_term>Respiratory Insufficiency</mesh_term>
	<mesh_term>Pulmonary Valve Stenosis</mesh_term>
	<criteria>Age great equal 10 year age Body weight great equal 30 kilogram Pulmonary regurgitation ≥moderate pulmonary regurgitation ( PR ) ( ≥3+ ) RVOT conduit obstruction mean gradient &gt; 35mmHg echocardiography pulmonary artery annulus situ conduit size ≥16 ≤26mm Patient willing provide write informed consent comply followup requirement Preexisting mechanical heart valve position Obstruction central vein ( pulmonic bioprosthesis delivery system heart ) Coronary artery compression A know hypersensitivity Aspirin Heparin Immunosuppressive disease Active infectious disease ( e.g . endocarditis , meningitis ) Estimated survival less 6 month Female childbearing potential unable take adequate contraceptive precaution , know pregnant , currently breastfeed infant .</criteria>
	<gender>All</gender>
	<minimum_age>10 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2017</verification_date>
	<keyword>Pulmonary Valve</keyword>
	<keyword>Transcatheter Pulmonary Valve</keyword>
	<keyword>Congenital Heart Disease</keyword>
</DOC>